| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.6M | -12.1% |
| Cost of Revenue | $6.7M | +2.6% |
| Gross Profit | $18.0M | -16.6% |
| R&D Expense | $5.9M | -26.3% |
| SG&A Expense | $8.0M | -41.5% |
| Operating Income | -$600K | +92.8% |
| Interest Expense | $2.2M | -1.7% |
| Pre-tax Income | -$1.9M | +81.7% |
| Income Tax | $3K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +256.2% |
| Accounts Receivable | $2.2M | -24.9% |
| Current Assets | $3.9M | -13.1% |
| Total Assets | $6.8M | +33.7% |
| Current Liabilities | $5.7M | -58.2% |
| Long-term Debt | $8.4M | — |
| Total Liabilities | $16.6M | +20.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$953K | +76.0% |
| Capital Expenditures | $64K | -81.8% |
| Investing Cash Flow | -$64K | +81.8% |
| Financing Cash Flow | $1.9M | +67.7% |
| Free Cash Flow | -$1.0M | +76.5% |
| -25.0% |
| Net Income | -$1.9M | +81.7% |
| EPS (Basic) | -$0.04 | +85.7% |
| EPS (Diluted) | -$0.04 | +85.7% |
| Stockholders' Equity |
| -$9.8M |
| -12.6% |